Saxagliptin, alogliptin neither help nor harm CV risk in diabetics

However, there was an increased risk of hospitalizations for heart failure among patients treated with saxagliptin. On the whole, however, cardiologists feel the results are helpful for colleagues treating diabetic patients, as they rule out a risk of MI, stroke, or cardiovascular mortality.
Source: theHeart.org - Category: Cardiology Source Type: news